| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.AJOG.2011.06.049 |
| P698 | PubMed publication ID | 21861962 |
| P50 | author | Jason D Wright | Q92492528 |
| P2093 | author name string | Xuming Sun | |
| Sharyn N Lewin | |||
| Thomas J Herzog | |||
| William M Burke | |||
| Israel Deutsch | |||
| Maria B Schiavone | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Mucinous carcinoma | Q6931137 |
| P304 | page(s) | 480.e1-8 | |
| P577 | publication date | 2011-06-21 | |
| P1433 | published in | American Journal of Obstetrics and Gynecology | Q4744256 |
| P1476 | title | Natural history and outcome of mucinous carcinoma of the ovary | |
| P478 | volume | 205 |
| Q38168731 | A recurrence-predicting prognostic factor for patients with ovarian clear-cell adenocarcinoma at reproductive age. |
| Q57210147 | Adequate pelvic lymphadenectomy and survival of women with early-stage epithelial ovarian cancer |
| Q34121532 | Association of pancreatic adenocarcinoma up-regulated factor expression in ovarian mucinous adenocarcinoma with poor prognosis |
| Q28294243 | Carcinosarcoma of the ovary: natural history, patterns of treatment, and outcome |
| Q36922328 | Clinical Outcomes among Women with Mucinous Adenocarcinoma of the Ovary |
| Q36817504 | Comparison of advanced stage mucinous epithelial ovarian cancer and serous epithelial ovarian cancer with regard to chemosensitivity and survival outcome: a matched case-control study |
| Q58096673 | Comparison of stage III mucinous and serous ovarian cancer: a case-control study |
| Q38382139 | Early stage primary ovarian mucinous carcinoma: Outcome-based clinicopathological study in comparison with serous carcinoma |
| Q91674970 | Effectiveness of postoperative chemotherapy for stage IC mucinous ovarian cancer |
| Q92747182 | Evolving population-based statistics for rare epithelial ovarian cancers |
| Q38080036 | Extremely poor postrecurrence oncological outcome for patients with recurrent mucinous ovarian cancer |
| Q34688984 | HER2 amplification and clinicopathological characteristics in a large Asian cohort of rare mucinous ovarian cancer |
| Q56334183 | Histotype classification of ovarian carcinoma: A comparison of approaches |
| Q90396711 | Identification of PLK1 as a New Therapeutic Target in Mucinous Ovarian Carcinoma |
| Q52714804 | Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage. |
| Q35908816 | Long-term mortality among women with epithelial ovarian cancer |
| Q58110917 | Missing information in statewide and national cancer databases: Correlation with health risk factors, geographic disparities, and outcomes |
| Q36157106 | Morphologic and Molecular Characteristics of Mixed Epithelial Ovarian Cancers. |
| Q92867301 | Mutually exclusive antiproliferative effect of cell line-specific HOX inhibition in epithelial ovarian cancer cell lines: SKOV-3 vs RMUG-S |
| Q37684455 | NOTCH2 expression is decreased in epithelial ovarian cancer and is related to the tumor histological subtype |
| Q28547093 | Nutlin-3a: A Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian Carcinomas |
| Q37632101 | Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria |
| Q38007297 | Ovarian low-grade serous carcinoma: a comprehensive update |
| Q34504603 | Prognostic significance of mucinous differentiation of endometrioid adenocarcinoma of the endometrium |
| Q60302394 | Prognostic significance of preoperative serum CEA in primary mucinous ovarian carcinoma: a retrospective cohort study |
| Q55609057 | Recent Insights into Mucinous Ovarian Carcinoma. |
| Q28083904 | The molecular background of mucinous carcinoma beyond MUC2 |
| Q92578672 | Trends and characteristics of epithelial ovarian cancer in Japan between 2002 and 2015: A JSGO-JSOG joint study |
| Q28536689 | Type-specific cell line models for type-specific ovarian cancer research |
| Q52861155 | [Grading of gynecological tumors : Current aspects]. |
Search more.